DefEYE, Inc.
PrivateLast Round
Seed
Oct 22, 2025
Est. Valuation
$31M
Total Funding Raised
$12M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
DefEYE, Inc. is a biotechnology company that develops and commercializes decellularized biologic solutions, including amniotic barrier membranes, for the management of ocular surface diseases and surgical recovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DefEYE, Inc. Comparables
Compare DefEYE, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Merakris Therapeutics | 87% | |
| Oculus Biologics | 86% | |
| Skye Biologics Holdings | 85% | |
DefEYE, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 22, 2025 |
DefEYE, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ExSight Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 3, 2026
Grew 23% QoQ, from 13 to 16 employees.
- Jul 30, 2026
Grew 45% QoQ, from 11 to 16 employees.
DefEYE, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about DefEYE, Inc.'s valuation, stock price, and market status.